Table 1 Description of KD cohorts with and without coronary artery aneurysms used in this analysis.
Cohort | Source | Platform | CAA+: n (% male) | CAA−: n (% male) | Total: n (% male) | ||
|---|---|---|---|---|---|---|---|
Small–medium CAA | Giant CAA | CAA+ subtotal | |||||
1 | US | Illumina 1.2 million SNV array | 10 (70) | 0 | 10 (70) | 30 (60) | 40 (63) |
2 | US | Illumina HumanCoreExome array customized | 63 (63) | 35 (60) | 98 (62) | 40 (78) | 138 (67) |
Finland | 8 (63) | 4 (75) | 12 (67) | 36 (67) | 48 (67) | ||
3 | UK | Illumina HumanCoreExome array | 46 (70) | 1 (100) | 47 (70) | 122 (65) | 169 (66) |
Holland | 21 (71) | 12 (92) | 33 (79) | 48 (46) | 81 (59) | ||
Total | 148 (67) | 52 (69) | 200 (68) | 276 (63) | 476 (65) | ||
